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Abstract
Introduction and hypothesis The objective of our study was
to estimate the incidence and to identify the risk factors for
reoperation of surgically treated pelvic organ prolapse
(POP).
Methods We conducted a nested case–control study among
1,811 women who underwent POP surgery from January
1988 to June 2007. Cases (n=102) were women who
required reoperation for POP following the first interven-
tion through December 2008. Controls (n=226) were
women randomly selected from the same cohort who did
not require reoperation.
Results The incidence of POP reoperation was 5.1 per 1,000
women-years. The cumulative incidence was 5.6%. Risk
factors included preoperative prolapse in more than two
vaginal compartments (adjusted OR 5.2; 95% CI 2.8–9.7),
history of surgery for POP and/or urinary incontinence
(adjusted OR 3.2; 95% CI 1.5–7.1), and sexual activity
(adjusted OR 2.0; 95% CI 1.0–3.7).
Conclusions The risk of POP reoperation is relatively low
and is associated with preexisting weakness of pelvic tissues.
Keywords Nested case–control study . Pelvic organ
prolapse . Incidence . Risk factors . Reoperation
Abbreviations
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CI Confidence interval
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Introduction
Surgery for pelvic organ prolapse (POP) and urinary
incontinence is common. The lifetime risk of undergoing
a first procedure was estimated to be between 11% and 19%
[1–3]. The prevalence of reoperation reported in some
studies is high (43–56%) but likely overestimated as these
studies included genital prolapse after Burch colposuspen-
sion [4, 5]. Prevalence of reoperation for POP or urinary
incontinence was 29.2% in a community-based population
[1]. Therefore, in an attempt to improve outcomes and
based on this high risk of recurrence, surgeons increasingly
use prosthetic materials for the treatment of POP to limit
the risk of recurrence. The use of mesh is nevertheless
associated with a non-negligible risk of complications such
as vaginal erosions, granulomas, dyspareunia, vesico-
vaginal fistulas, and increase in overactive bladder symp-
toms, thereby potentially reducing the quality of life of
women [6–8]. Recent studies reported lower rates (between
1.5% and 13%) of reoperation for surgically treated POP
and urinary incontinence [9–11]. In another recent study,
the risk of POP recurrence after reconstructive pelvic
surgery without using prosthetic material was 10% [12].
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Very little is known on the factors associated with surgical
failure. Data arise from a few studies with few identified risk
factors. Younger age, high BMI, and advanced preoperative
prolapse (grade III–IV) were associated with an increased risk
of reoperation in some studies [9, 12, 13]. However, these
results were contradicted by other studies in which these
associations were not observed [2, 10]. History of surgery for
POP and/or urinary incontinence at the time of primary
surgery was associated with an increased risk of reoperation
in two studies [10, 14].
Based on our clinical experience, we hypothesized that
the risk of reoperation would be lower than some of the
above-mentioned estimates [1, 4, 5]. The purpose of this
study was to estimate the incidence and identify the risk
factors for POP reoperation after previous POP reconstruc-
tive surgery.
Materials and methods
We performed a case–control study nested within a cohort.
This study was approved by the Institutional Ethics
Committee of the Geneva University Hospitals (protocol
number 07-242R). We identified, by using a computerized
medical record database, all women (N=1,811) who
underwent POP surgery in the Department of Obstetrics
and Gynecology, Geneva University Hospitals, from Janu-
ary 1988 to June 2007. This is a teaching hospital where all
women had their operation performed either by a super-
vised resident in gynecological surgery or by an experi-
enced gynecological surgeon (consultant, professor). Cases
(n=102) were women of this cohort who required reoper-
ation for recurrent POP following the first intervention
through December 2008 in our institution. Because our
hospital is the only public institution in the canton of
Geneva and women needing a reoperation cannot be treated
either outside the canton or in private institutions, we
believe that most cases were identified using this strategy.
Controls (n=226) were patients, randomly selected from
the same cohort, who did not require reoperation for POP
during the same period. We selected all cases and drew a
sample of controls (two controls per case) from the hospital
database which includes all women who had POP surgery.
We calculated that a sample size of 309 women with 103 cases
and 206 controls had a power of 80% with a two-tailed alpha
of 0.05 to demonstrate statistical significance of odds ratios of
2 in a plausible range of probability of exposure to a risk
factor. We selected a few more controls to reach the desired
number in case of unavailable medical charts.
Cases and controls for whom medical records were not
available were excluded from the analysis (n=2). To avoid
bias in the evaluation of risk factors, data were collected in
the medical charts blinded to the study group. The medical
charts were photocopied and stripped of a patient’s identity.
The part concerning the first intervention was separated
from that of the second in cases. One of the authors (CJ)
reviewed all the medical charts related to the first
intervention (328 surgically treated pelvic organ prolapse)
and another one (PD) reviewed the charts related to the
second intervention (102 reoperations for recurrent pro-
lapse). Variables extracted from the charts included age,
weight, height, parity, number of vaginal deliveries,
previous cesareans, menopausal status, hormonal replace-
ment therapy, smoking, constipation, chronic obstructive
pulmonary disease, cardio-vascular disease, and history of
surgery for genital prolapse or urinary incontinence per-
formed outside our institution or outside the study period.
All women had a standardized preoperative prolapse
assessment, using the Baden–Walker classification, which
was the classification system used in our institution during
the study period [15]. The grade of cystocele, uterine or
vaginal vault prolapse, rectocele, and enterocele, as well as
the grade of urinary stress incontinence, were identified. In
the analysis, we discussed pelvic organ prolapse in terms of
segments of the vaginal wall rather than the organ that lies
behind, as described by Bump et al. [16]. We considered
three major vaginal compartments: the anterior vaginal
wall, the posterior vaginal wall, and the superior vagina
comprising the cervix or the vaginal vault. We considered
prolapse of the posterior fornix (pouch of Douglas) as a
fourth vaginal segment in a woman who still had a cervix
[16]. The date and indication for POP surgery were
collected, as well as the route of POP surgery (abdominal,
vaginal, or laparoscopic) and the use of prosthetic material.
The surgical techniques used in our institution for abdom-
inal and vaginal POP reconstruction were those described
by Hirsch et al. [17]. Most of the procedures were
conventional vaginal POP repairs without mesh, which
were the techniques performed in our institution from 1988
to 2003. Laparoscopic POP reconstruction techniques were
the ones developed by Dubuisson et al. and included the
use of mesh from 2003 onwards [18]. Concomitant
procedures such as urinary incontinence repair or hysterec-
tomy were also identified. Post-operative complications
such as fever or vault abscess were systematically searched.
Cases and controls were compared for the predictor
variables mentioned above. Differences in proportions were
tested with chi-square test or Fisher exact test. Differences
in continuous variables were tested using t-test. We
performed a univariable analysis to compute the odds ratios
(ORs) for each predictor. Variables found to be statistically
associated with the outcome or clinically important were
then entered in logistic regression models to compute
adjusted odds ratios. A P-value less than 0.05 was
considered as statistically significant and 95% confidence
intervals (CIs) were reported. The annual incidence of
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reoperation was computed taking into account the fact that
only a sample of the potential controls was included. We
multiplied the number of person-years at risk of controls by
the sampling fraction (226/1,811). Data were managed and
analyzed with Epi-Info 6 (Centers of Disease Control and
Prevention, Atlanta, GA, USA) and SPSS 15.0 statistical
software (SPSS Inc., Chicago, IL, USA).
Results
Between January 1988 and June 2007, 1,811 consecutive
POP surgeries were performed in our institution. The
incidence of POP reoperation was 5.1 per 1,000 women-
years. Between January 1988 and December 2008, 102
women of this cohort were reoperated for subsequent POP,
a cumulative incidence of 5.6%. The mean interval between
operations was 3.4 years (range, 2 months to 15.8 years) in
the case group and the mean duration of follow-up was
11.4 years (range, 1.8 to 22.0 years) in controls. Only two
women in the case group and none in the control group was
Fig. 1 Number of cases of
reoperation per ongoing year
Table 1 Characteristics of the study population at first POP
intervention
Cases (n=100) Controls (n=226) P
Age (year), mean (SD) 58.5 (12.2) 62.3 (13.5) 0.02
Height (cm) mean (SD) 159.7 (6.9) 159.1 (6.4) 0.45
Weight (kg) mean (SD) 66.7 (11.4) 67.0 (11.6) 0.85
BMI (kg/m2) mean (SD) 26.2 (4.4) 26.4 (4.7) 0.70
Menopause n (%)a 65 (65.0) 172 (76.0) 0.14
HT, n (%)a 20 (20.0) 44 (19.5) 1.00
Diabetes, n (%)a 7 (7.0) 19 (8.4) 0.83
Asthma or COPD, n (%)a 1 (1.0) 5 (2.2) 0.67
Smoking>5 cigarettes/day, n (%)b 13 (13.0) 27 (11.9) 0.72
Cardio-vascular disease, n (%) 3 (3.0) 18 (8.0) 0.05b
Constipation, n (%)c 33 (33.0) 57 (25.2) 0.22
Sexual activity, n (%)c 67 (67.0) 106 (46.9) 0.001
P values are calculated with the Fisher exact test for proportions and
with the t-test for means unless specified
BMI body mass index, HT hormonal replacement therapy, COPD
chronic obstructive pulmonary disease
a There was one missing value in the case group
b There were three missing values in the case group
c There were respectively 10 and 11 missing values in the case group
and 30 and 29 in the controls, with similar percentages for the two
groups, for constipation and sexual activity
Table 2 Description of preoperative POP at first intervention
Cases (n=100) Controls (n=226)
POP Grade 1 and 2 31 (31.0) 81 (35.8)
POP Grade 3 and 4 69 (69.0) 145 (64.2)
Cystocele
None 3 (3.0) 36 (15.9)
Grade 1 and 2 52 (52.0) 84 (37.2)
Grade 3 and 4 45 (45.0) 106 (46.9)
Uterine prolapse
None 24 (24.0) 92 (40.7)
Grade 1 and 2 59 (59.0) 89 (39.4)
Grade 3 and 4 17 (17.0) 45 (19.9)
Vaginal vault prolapse
None 93 (93.0) 209 (92.5)
Grade 1 and 2 3 (3.0) 12 (5.3)
Grade 3 and 4 4 (4.0) 5 (2.2)
Rectocele
None 31 (31.0) 116 (51.3)
Grade 1 and 2 56 (56.0) 90 (39.8)
Grade 3 and 4 13 (13.0) 20 (8.9)
Enterocele
None 94 (94.0) 218 (96.5)
Grade 1 and 2 3 (3.0) 5 (2.2)
Grade 3 and 4 3 (3.0) 3 (1.3)
Data are presented as n (%)
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excluded from the analysis because records were not
available or risk factors were missing This left 100 cases
and 226 controls for the analysis. The number of cases per
ongoing year is shown in Fig. 1. Half of the cases were
reoperated within 2 years (Fig. 1).
The mean age was different, while the mean body mass
index (BMI) was similar between groups (Table 1). The
distribution of preoperative POP characteristics at first
intervention is described in Table 2. Table 3 describes the
distribution of preoperative POP at first intervention
according to the number of prolapsed vaginal wall segment
of any grade.
In univariable analysis, risk factors included age≤
70 years (odds ratio (OR) 1.9; 95% confidence interval
(CI) 1.1–3.5; P=0.024), sexual activity (OR 2.6; 95% CI
1.5–4.6; P=0.01), and history of surgery for POP and/or
urinary incontinence (OR 2.7; 95% CI 1.3–5.5; P=0.007).
Multiparity, vaginal deliveries, constipation, pulmonary
disease, and previous hysterectomy were not associated
with a higher risk of reoperation (Tables 1 and 4). The stage
of POP assigned according to the most severe portion of the
prolapse did not differ between groups. Preoperative POP≥
stage 3 was present in 69.0% of cases and 64.2% of
controls (OR 1.2; 95% CI 0.8–2.1; P=0.45) (Table 2).
However, the number of prolapsed vaginal segments of any
grade involved in the pelvic floor defect differed between
groups, and the presence of POP in more than two vaginal
segments in the same patient was a significant risk factor
(OR 2.7; 95% CI 1.7–4.4; P<0.001) (Table 3). Regarding
the access, most of the patients were operated through a
vaginal approach. There was no difference according to the
type of surgical approach (vaginal, abdominal, and laparo-
scopic) (Table 5). The absence of posterior repair at initial
surgery increased the risk of reoperation (OR 1.7; 95% CI
1.0–2.8; P=0.04). Concomitant urinary incontinence repair
(OR 1.3; 95% CI 0.7–2.1; P=0.39) or hysterectomy (OR
1.2; 95% CI 0.7–2.1; P=0.44) did not increase the risk of
reoperation. Vaginal approach was a protective factor,
although not statistically significant (OR 0.5; 95% CI
0.3–1.0; P=0.06). The use of mesh was not a protective
factor (OR 1.4; 95% CI 0.6–3.1; P=0.51). The weight of
the uterus, in case of hysterectomy, and post-operative
complications were similar in both groups (Table 5).
In multivariable analysis, when all statistically signifi-
cant variables were taken into account, age≤70 years was
no longer a risk factor. Sexual activity remained a risk
factor (adjusted OR 2.0; 95% CI 1.0–3.7; P=0.022)
independently of age. The most important risk factors in a
multivariable analysis were the presence of POP in more
than two vaginal segments (adjusted OR 5.2; 95% CI 2.8–
9.7; P<0.001), history of surgery for POP and/or urinary
incontinence (adjusted OR 3.02; 95% CI 1.4–6.3; P=0.003),
and the absence of posterior repair at initial surgery (OR 2.9;
95 CI 2.8–9.7; P<0.001) (Table 6).
Table 3 Description of preoperative POP according to the number of
prolapsed vaginal segments (anterior and posterior vaginal wall,
superior vagina, and posterior fornix) of any grade at first intervention
Number of vaginal wall
segments protruding
Cases (n=100) Controls (n=226)
One segment 7 (7.0) 72 (31.9)
Two segments 35 (35.0) 78 (34.5)
Three segments 54 (54.0) 73 (32.3)
Four segments 4 (4.0) 3 (1.3)
Data are presented as n (%)
Cases (n=100) Controls (n=226) Unadjusted OR (95% CI) P
Parity
Nulliparous 5 (5.0) 8 (3.5) Reference
Multiparous 95 (95.0) 218 (96.5) 0.7 (0.2–2.2) 0.55
Vaginal delivery
None 5 (5.0) 10 (4.4) Reference
One or more 95 (95.0) 216 (95.6) 0.9 (0.3–2.6) 0.78
Cesarean section
None 96 (96.0) 219 (96.9) Reference
One or more 4 (4.0) 7 (3.1) 1.3 (0.4–4.6) 0.74
Previous POP or incontinence surgery
None 82 (82.0) 209 (92.5) Reference
One or more 18 (18.0) 17 (7.5) 2.7 (1.3–5.5) 0.007
Previous hysterectomya 9 (9.0) 34 (15.0) 0.6 (0.2–1.3) 0.16
None 90 (90.0) 192 (85.0) Reference
Table 4 Risk factors for POP
reoperation: obstetric history
and previous pelvic surgery
P values are calculated with the
Fisher exact test. Data are pre-
sented as n (%)
OR odds ratios, CI confidence
interval, POP pelvic organ
prolapse
a The percentages do not add to
100 because there was one miss-
ing value in the case group
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Discussion
Our study suggests that the risk of reoperation after POP
surgery is relatively low and associated with variables
indicating preexisting weakness of pelvic floor tissues.
History of surgery for POP and/or urinary incontinence and
an increasing number of prolapsed segments of the lower
reproductive tract before reconstructive pelvic surgery are
the main risk factors for reoperation.
We systematically searched MEDLINE (search terms:
“reoperation for surgically treated/managed pelvic organ
prolapse, recurrent pelvic organ prolapse, follow-up stud-
ies”, all languages, from 1966 to 2010) and found few
studies reporting the incidence of reoperation for recurrent
POP. Most authors measured the combined risk of reoper-
ation for surgically treated prolapse and urinary inconti-
nence, thus overestimating the rate for POP reoperation
alone. The risk of reoperation for POP or urinary
incontinence of 29.2% frequently quoted as a reference in
further studies results to a retrospective cohort study of 384
women [1]. The same cohort was followed prospectively
and the cumulative incidence of reoperation for POP and
urinary incontinence at 5 and 10 years was 13% and 17%,
respectively [10, 14]. The risk of reoperation for POP
alone, during a 5-year follow-up, was much lower (1.5%) in
another study. The risk was probably underestimated as a
low percentage of women (58.8%) agreed to the 5-year
follow-up [9]. In a large cohort comprising 2,099 women,
Table 5 Risk factors for POP reoperation: primary operation
Cases (n=100) Controls (n=226) Unadjusted OR (CI 95%) P
Abdominal approacha 5 (5.0) 9 (4.0) 1.3 (0.4–3.9) 0.77
Vaginal approacha 83 (83.0) 205 (90.7) 0.5 (0.3–1.00) 0.06
Laparoscopic approacha 16 (16.0) 23 (10.2) 1.7 (0.9–3.3) 0.14
Use of mesh 10 (10.0) 17 (7.5) 1.4 (0.6–3.1) 0.51
Types of prolapse intervention
Anterior colporraphy 77 (77.0) 185 (81.9) 0.7 (0.4–1.3) 0.36
Posterior colporraphy 40 (40.0) 119 (52.7) 0.6 (0.4–1.0) 0.04
Vault suspension 13 (13.0) 22 (9.7) 1.4 (0.7–1.9) 0.44
Enterocele repair 4 (4.0) 7 (3.1) 1.3 (0.4–4.6) 0.74
Culdoplasty 17 (17.0) 11 (4.9) 4.0 (1.8–8.9) 0.01
Urinary incontinence repair
None 66 (66.0) 161 (71.2) Reference
Slingplasty 22 (22.0) 49 (21.7) 1.0 (0.6–1.8) 1.0
Colposuspension 12 (12.0) 16 (7.1) 1.8 (0.8–3.9) 0.20
Any 34 (34.0) 65 (28.8) 1.3 (0.7–2.1) 0.39
Associated hysterectomyb
None 29 (29.0) 76 (33.6) Reference
Subtotal 2 (2.8) 0 NA
Total 69 (69.0) 150 (66.4) 1.2 (0.7–2.1) 0.48
Any 71 (71.0) 150 (66.4) 1.2 (0.7–2.1) 0.44
Mean weight of uterus in grams (SD) 87.8 (66.9) 91.7 (160.9) 0.87
Post-operative complications
None 95 (95.0) 217 (96.0) Reference
Fever>38°C 4 (4.0) 7 (3.1)
Vaginal vault abscess 2 (2.0) 1 (0.4)
Hematoma 2 (2.0) 3 (1.3)
Anyc 5 (5.0) 9 (4.0) 1.3 (0.4–3.9) 0.77
Data are presented as n (%) except for the weight of the uterus. P values are calculated with the Fisher exact test for proportions and with the t-test
for means unless specified
a The numbers do not add up to 326 because some patients had combined approaches (abdominal and vaginal in nine and laparoscopic and vaginal
in six)
b One missing information in the control group
c The numbers do not add up to 100 because some patients combined fever with hematoma or abscess
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the majority of repeat procedures did not involve the same
compartment as the initial operation, and the overall
cumulative rate of reoperation following surgery for POP
was 11.8 at 11 years, which is closer to our cumulative
incidence of 5.6% [11]. Similarly, a recent study based on
the Western Australian Data Linkage System identified
51,137 women who underwent surgery for POP between
1981 and 2005. Surgery was a first-time procedure in
44,728 women (87.5%); thereby, the remaining 6,409
(12.5%) should be a repeated procedure [3]. The incidence
is influenced by access to medical care and financial
considerations, rending comparisons between different
populations difficult. The difference with higher rates might
be partly explained by operations performed outside our
university clinic and not included in our cohort, resulting in
an underestimation of the real incidence. However, that
number is probably low as our clinic is the only public
institution in the canton of Geneva. Women followed in
public hospitals in Switzerland rarely go to private clinics
due to their lack of private health insurance coverage, and
Swiss health insurances only exceptionally accept that a
patient be operated in another canton or country. Surgically
treated prolapse represents the severe end of the spectrum
of POP. The anatomical recurrence rate in our cohort is
probably higher; but, in most cases, women are asymptom-
atic and do not require surgery. In a cohort of 389 women
who underwent POP vaginal repair, recurrence (stage 2 or
more) was observed in 58% of the women after only 1 year
[13]. However, only 9.7% had prolapse protruding beyond
the hymen. In another study, anatomical failure (vaginal
wall prolapse stage 2 or more) was 31.3%, but only 7.4%,
which is close to our risk of reoperation of 5.6%, had POP-
related symptoms[9].
Little is known about the risk factors that prevent or
promote recurrence and consecutive reoperation. Similar to
other authors, we found that POP severity, expressed as the
most distal preoperative POP stage, did not increase the risk
of reoperation, neither did advancing age, BMI, and vaginal
deliveries [14, 19]. However, an important finding of our
study was that the number of prolapsed vaginal wall
segments and the absence of complete repair at initial
surgery increased the risk of reoperation. Severity of
prolapse should take into account not only the stage of
the most distal end but also the number of compartments
involved. The absence of posterior repair at initial surgery
was associated with an increased risk of reoperation and
suggests that it might be worthwhile to repair any posterior
vaginal prolapse, even asymptomatic, at the time of primary
surgery.
We found that the history of surgery for POP and/or
urinary incontinence, before the primary pelvic floor
reconstruction, increased the risk of reoperation, suggesting
the presence of preexisting weakness of pelvic floor tissues,
as shown in previous reports [10]. It is nowadays widely
accepted that underlying connective abnormalities, as well
as hereditary factors, predispose to POP, and our study
shows that they also predispose to POP recurrence [20–23].
Our study suggested that sexual activity significantly
increased the risk for pelvic floor reoperation following
primary surgical management. Women who are sexually
active may actively seek POP surgery, explaining the higher
risk of reoperation in this population, independently from
age as shown by the multivariable model. There may be an
association with other variables influencing the decision to
operate, such as the physical condition of the patient.
However, we have no other variable to confirm this
hypothesis. We may also hypothesize that mechanical
factors associated with sexual activity increase the risk of
subsequent genital prolapse. We found a similar association
in a previous report [24].
During most of the study period (1988–2003),
concerning more than 80% of our patients, women were
operated with conventional vaginal prolapse surgery, with-
out the use of any prosthetic material. Based on previous
reports, we would expect a high rate of reoperation, which
is not the case. Our study supports the idea that conven-
tional vaginal surgery is effective to treat POP. The number
of abdominal and laparoscopic POP repair was too small in
our cohort to draw any conclusion. The use of mesh was
not associated with a lower risk of reoperation, but the
number, too, was small. The learning curve associated with
the use of vaginal or laparoscopic mesh could explain the
lack of benefit observed as it was our initial experience.
However, the benefit of prosthetic material on the risk of
POP recurrence still remains to be proven, as shown in a
recent randomized controlled trial [25].
The limitations of our study included those typical of
studies relying on information collected in medical records.
Despite similar efforts to trace the medical charts, two
Table 6 Risk factors for prolapse reoperation: multivariable analysis.
Odds ratios and 95% confidence intervals were adjusted for the other




Age≤70 years 1.3 (0.6–2.6) 0.49
Sexual activity 2.0 (1.0–3.7) 0.04
Premenopause 1.4 (0.8–2.5) 0.29
Absence of posterior repair 2.9 (1.5–5.5) 0.001
Previous POP and incontinence
surgery
3.2 (1.5–7.1) 0.003
POP in more than two vaginal
compartments
5.2 (2.8–9.7) <0.001
P values are calculated with the chi-square test unless specified. Each
OR and 95% CI is adjusted for all other covariates listed in this table
40 Int Urogynecol J (2012) 23:35–41
medical records were not available in the case group. The
unavailable records might have been due to changing
names as in Switzerland individuals do not have a unique
identifier.
The strength of this study was the availability of a
continuously updated computerized register, which allowed
us to identify cases and controls in the same large cohort
with a long follow-up. Another strength was the preoper-
ative standardized assessment of the genital prolapse
according to the Baden–Walker classification. The assess-
ment of prolapse was more precise than in studies using
questionnaires.
Based on our data and recent studies, we believe the risk
of reoperation for recurrence after POP reconstructive
surgery to be between 6% and 12% rather than 30% as
previously described. The risk of recurrence being associ-
ated with the number of prolapsed vaginal compartments, it
might be important to repair all segments at index surgery.
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